Arix Bioscience PLC (GB:ARIX)

Arix Bioscience (ARIX) Share Price & Analysis


ARIX Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range99.60p - 124.00p
Previous Close104p
Average Volume (3M)94.18K
Market Cap
Enterprise Value520.31B
Total Cash (Recent Filing)£122.78M
Total Debt (Recent Filing)£70.00K
Price to Earnings (P/E)-5.1
Aug 10, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding135,659,324
10 Day Avg. Volume220,276
30 Day Avg. Volume94,184
Standard Deviation0.15
Financial Highlights & Ratios
Price to Book (P/B)62.15
Price to Sales (P/S)477416.28
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0




What was Arix Bioscience PLC’s price range in the past 12 months?
Arix Bioscience PLC lowest share price was 99.60p and its highest was 124.00p in the past 12 months.
    What is Arix Bioscience PLC’s market cap?
    Currently, no data Available
    When is Arix Bioscience PLC’s upcoming earnings report date?
    Arix Bioscience PLC’s upcoming earnings report date is Aug 10, 2023 which is in 63 days.
      How were Arix Bioscience PLC’s earnings last quarter?
      Arix Bioscience PLC released its earnings results on Apr 25, 2023. The company reported 0.02p earnings per share for the quarter, beating the consensus estimate of N/A by 0.02p.
        Is Arix Bioscience PLC overvalued?
        According to Wall Street analysts Arix Bioscience PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Arix Bioscience PLC pay dividends?
          Arix Bioscience PLC does not currently pay dividends.
          What is Arix Bioscience PLC’s EPS estimate?
          Arix Bioscience PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Arix Bioscience PLC have?
          Arix Bioscience PLC has 129,389,510 shares outstanding.
            What happened to Arix Bioscience PLC’s price movement after its last earnings report?
            Arix Bioscience PLC reported an EPS of 0.02p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.99%.
              Which hedge fund is a major shareholder of Arix Bioscience PLC?
              Currently, no hedge funds are holding shares in GB:ARIX


              Arix Bioscience Stock Smart Score

              The Arix Bioscience Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Arix Bioscience PLC

              Arix Bioscience PLC is a healthcare and life science company. Its business model is to source, finance and develop healthcare and life science businesses that deliver or seek to deliver innovative therapies to patients. Its segment includes sourcing, financing and developing healthcare and life science businesses globally. The company's revenue is derived from the United Kingdom.


              Top 5 ETFs holding ARIX

              Currently, no data available
              Please return soon. This page is being updated.
              Up to five ETFs with an Outperform Smart Score that hold ARIX. The ETFs are listed according to market value of ARIX within the ETF


              Forecast EPS vs Actual EPS

              Similar Stocks
              Price & Change
              Assura plc
              Record plc
              Premier Asset Management

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis